GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Institutional Ownership

Abbisko Cayman (STU:8ZD) Institutional Ownership : 7.33% (As of Jun. 20, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Abbisko Cayman's institutional ownership is 7.33%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Abbisko Cayman's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Abbisko Cayman's Float Percentage Of Total Shares Outstanding is 0.00%.


Abbisko Cayman Institutional Ownership Historical Data

The historical data trend for Abbisko Cayman's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Institutional Ownership Chart

Abbisko Cayman Historical Data

The historical data trend for Abbisko Cayman can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 4.00 4.00 4.00 4.24 6.71 6.90 6.91 7.21 7.30 7.33

Abbisko Cayman Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Abbisko Cayman (STU:8ZD) Business Description

Traded in Other Exchanges
Address
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (STU:8ZD) Headlines

No Headlines